Deepa Ramasamy
Overview
Explore the profile of Deepa Ramasamy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Govarthanan K, Ramasamy D, Richard A, Kathirvelu D, Verma R
Methods Mol Biol
. 2025 Feb;
2880:147-158.
PMID: 39900757
Epigenetic events such as DNA methylation and histone modifications affect a wide range of genomic functions without impacting the nucleotide sequence. Aberrant DNA methylation has been related to a variety...
2.
Ramasamy D, Thippannah M, Maharajan H, Balaiah M, Seshadri R, Kodous A, et al.
Mol Biol Rep
. 2024 Feb;
51(1):299.
PMID: 38345740
Background: N6-methyladenosine (m6A) is a prevalent and crucial RNA methylation modification that plays a significant role in various biological and pathological processes. The dysregulation of m6A has been linked to...
3.
Functional alteration due to structural damage is network dependent: insight from multiple sclerosis
Bartnik A, Fuchs T, Ashton K, Kuceyeski A, Li X, Mallory M, et al.
Cereb Cortex
. 2022 Dec;
33(10):6090-6102.
PMID: 36585775
Little is known about how the brain's functional organization changes over time with respect to structural damage. Using multiple sclerosis as a model of structural damage, we assessed how much...
4.
Ramasamy D, Rao A, Balaiah M, Vittal Rangan A, Sundersingh S, Veluswami S, et al.
Cells
. 2022 Oct;
11(19).
PMID: 36230901
An imbalance in DNA methylation is a hallmark epigenetic alteration in cancer. The conversion of 5-methylcytosine (5-mC) to 5-hydroxymethyl cytosine (5-hmC), which causes the imbalance, results in aberrant gene expression....
5.
Ramasamy D, Rao A, Rajkumar T, Mani S
Epigenomes
. 2022 Aug;
6(3).
PMID: 35997370
Cytosine methylation adjacent to adenine, thymine, and cytosine residues but not guanine of the DNA is distinctively known as non-CpG methylation. This CA/CT/CC methylation accounts for 15% of the total...
6.
Carolus K, Fuchs T, Bergsland N, Ramasamy D, Tran H, Uher T, et al.
J Neurol
. 2022 Apr;
269(8):4478-4487.
PMID: 35394170
Background And Purpose: White matter (WM) tract disruption impacts volume loss in connected deep gray matter (DGM) over 5 years in people with multiple sclerosis (PwMS). However, the timeline of...
7.
Fuchs T, Vaughn C, Benedict R, Weinstock-Guttman B, Bergsland N, Jakimovski D, et al.
Brain Imaging Behav
. 2022 Jan;
16(3):1252-1259.
PMID: 34985619
Background: Overall burden of white matter damage is associated with increased self-report fatigue severity in people with multiple sclerosis. However, a paradoxically opposite association was reported for white matter damage...
8.
Govarthanan K, Gupta P, Patra B, Ramasamy D, E B, Sharma V, et al.
3 Biotech
. 2021 Dec;
12(1):12.
PMID: 34966635
Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-021-03058-2.
9.
Ramasamy D, Rao A, Rajkumar T, Mani S
Brief Funct Genomics
. 2021 Jul;
20(5):304-311.
PMID: 34318313
The methylation of cytosine residues that precede adenine/thymine or other cytosine nucleotides instead of guanine in DNA is known as non-CpG methylation. It is a pronounced epigenetic modification with a...
10.
Rao A, Arvinden V, Ramasamy D, Patel K, Meenakumari B, Ramanathan P, et al.
J Cell Mol Med
. 2021 Feb;
25(8):3912-3921.
PMID: 33544410
Breast cancer is a major cause of cancer-related death in women worldwide. Non-coding RNAs are a potential resource to be used as an early diagnostic biomarker for breast cancer. Circular...